SoCO Journal Club · DAROMUN · Post-JC Pulse

Two-question post-meeting pulse for the SoCO Journal Club discussion of DAROMUN / PIVOTAL.

SoCO Journal Club · Post-JC pulse

DAROMUN · PIVOTAL

~30 sec

Question 1 of 2 After reviewing the data

Do not fill this out:

After reviewing the evidence

How compelling is the evidence for neoadjuvant DAROMUN?

Based on PIVOTAL, in appropriately selected patients with resectable stage III melanoma.

Very compelling Moderately compelling Interesting, but not yet practice-changing Not particularly compelling I’m unsure / need to understand the data better

Clinical interpretation

How strongly should these results influence current clinical practice?

For appropriately selected patients with resectable, injectable melanoma.

Practice-changing Substantially Moderately A little Not at all

Response received

Thanks.

We’ll use the aggregate responses to see whether the discussion changed the room’s view of the evidence.